ARACYTINE
CYTARABINE
Public price
436,00 MAD
Reimbursement base
436,00 MAD
Active substance
CYTARABINE
Reimbursable
What is this medicine?
A cell cycle phase-specific antineoplastic agent and nucleoside metabolic inhibitor that acts primarily through the inhibition of DNA polymerase.
Verified summary
CYTARABINE, POUDRE POUR SOLUTION INJECTABLE, 1 G, 1 FLACON 5 ML
Common uses
Treatment of newly diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in adults and pediatric patients 1 year and older.
Class
Nucleoside metabolic inhibitor
Availability note
Reimbursable
Hospital price
290,00 MAD
Strength
1 G
Form
POUDRE POUR SOLUTION INJECTABLE
Presentation
1 FLACON 5 ML
Type
P
Therapeutic class
ANTINEOPLASIQUE CYTOTOXIQUE
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2017-12-18: 436,00 MAD
Available presentations and strengths
ARACYTINE
100 MG · BOITE DE 1 AMPOULE
51,40 MAD
ARACYTINE 100 MG
100 MG · Boîte de 1
51,40 MAD
ARACYTINE
100 MG · 1 BOITE 1 AMPOULE INJECTABLE
54,40 MAD
ARACYTINE
500 MG · 1 FLACON 5 ML
232,00 MAD
ARACYTINE
500 MG · BOITE DE 1 FLACON
232,00 MAD
ARACYTINE 500 MG
500 MG · Boîte de 1 Flacon de en verre Injectable
232,00 MAD
ARACYTINE
1 G · BOITE DE 1 FLACON
321,00 MAD
ARACYTINE 1 G
1 G · 1 flacon en verre
321,00 MAD
ARACYTINE 1 G
1 G · Boîte de 1 flacon en verre
321,00 MAD